Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Article

Empowering Promotores de Salud as Partners in Cancer Education and Research in Rural Southwest Kansas

Ana Paula Cupertino
Mercedes Saint-Elin
Johana Bravo de los Rios
Edward F. Ellerbeck
K. Allen Greiner
Anna M. Nápoles
ONF 2015, 42(1), 15-22 DOI: 10.1188/15.ONF.15-22

Purpose/Objectives: To describe community-based participatory processes used to develop promotore training on cancer research, and to assess the feasibility of training promotores from rural communities to disseminate cancer research information.

Design: Prospective, cohort design.

Setting: Rural communities in the state of Kansas.

Sample: 34 Spanish-speaking promotores attended an information session; 27 enrolled and 22 completed training.

Methods: With input from a community advisory board, the authors developed a leadership and cancer curriculum and trained Spanish-speaking promotores to disseminate information on cancer research. Promotores completed pretraining and post-training surveys in Spanish to assess demographic characteristics and changes in knowledge of cancer, cancer treatment and cancer research studies, and intent to participate in cancer research.

Main Research Variables: Cancer knowledge, awareness of cancer clinical trials, interest in participating in cancer clinical research studies.

Findings: Compared to pretraining, after training, promotores were more likely to correctly define cancer, identify biopsies, describe cancer stages, and report ever having heard of cancer research studies.

Conclusions: Completion rates of the training and willingness to participate in cancer research were high, supporting the feasibility of training promotores to deliver community-based education to promote cancer research participation.

Implications for Nursing: Nursing professionals and researchers can collaborate with promotores to disseminate cancer education and research among underserved rural Latino communities in Kansas and elsewhere. Members of these communities appear willing and interested in improving their knowledge of cancer and cancer clinical trials.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or